NORTHERN TRUST CORP - EYEGATE PHARMACEUTICALS INC ownership

EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M107. A total of 17 filers reported holding EYEGATE PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of EYEGATE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$3,000
-25.0%
14,5530.0%0.00%
Q1 2019$4,000
-42.9%
14,5530.0%0.00%
Q4 2018$7,000
+40.0%
14,5530.0%0.00%
Q3 2018$5,000
-37.5%
14,5530.0%0.00%
Q2 2018$8,000
+33.3%
14,5530.0%0.00%
Q1 2018$6,000
-62.5%
14,5530.0%0.00%
Q4 2017$16,000
+23.1%
14,553
+29.1%
0.00%
Q3 2017$13,00011,2770.00%
Other shareholders
EYEGATE PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 1,616,000$1,891,0000.22%
SABBY MANAGEMENT, LLC 46,378$54,0000.00%
TWO SIGMA SECURITIES, LLC 32,022$37,0000.00%
Vantage Investment Advisors, LLC 6,500$8,0000.00%
IFP Advisors, Inc 25,800$30,0000.00%
Virtu Financial LLC 15,967$19,0000.00%
BANK OF AMERICA CORP /DE/ 524$1,0000.00%
WELLS FARGO & COMPANY/MN 100$00.00%
NORTHERN TRUST CORP 11,277$13,0000.00%
CREDIT SUISSE AG/ 30,000$35,0000.00%
View complete list of EYEGATE PHARMACEUTICALS INC shareholders